Jinrong Liu

Jinrong Liu is a seasoned professional in the field of regulatory affairs and drug metabolism, currently serving as Director and Global Regulatory Lead for Oncology Early Development at AbbVie since June 2015. Liu has held various positions at AbbVie, including Associate Director and Senior Manager in US/Canada Regulatory Strategy, where responsibilities included leading regulatory submissions and strategy for new drug applications. Prior experience at AbbVie also involved serving as a Senior Scientist specializing in Drug Metabolism and Pharmacokinetics, focusing on drug-drug interaction inquiries from regulatory authorities. Additionally, Liu's decade-long tenure at Abbott encompassed roles as Senior Scientist and Research Pharmacologist, contributing to drug development in antiviral and oncology areas. Educational qualifications include a PhD in Drug Metabolism and Pharmacokinetics from The University of Texas at Austin, an MBA from Lake Forest Graduate School of Management, and a certificate in Regulatory Affairs from Kellogg Executive Education.